As one of the world's leading universities, the University of British Columbia creates an exceptional learning environment that fosters global citizenship, advances a civil and sustainable society, and supports outstanding research to serve the people of British Columbia, Canada and the world.

Latest Articles

View All Articles
View all Blogs

Strategic Priorities

Improving Student Funding
Promoting Excellence in Graduate Programs
Enhancing Graduate Supervision
Advancing Indigenous Inclusion
Supporting Student Development and Success
Reimagining Graduate Education
Enriching the Student Experience
Dr. Kuhlmann studied how a mutation in the LRRK2 gene and its corresponding protein alters neurotransmission in Parkinson's disease. She found that the mutation disrupts glutamate transmission in young mice, which may contribute to disease onset. A drug targeting LRRK2 function restored normal neurotransmission, suggesting its treatment potential.

A randomly-selected Doctoral citation each day: today from the Doctor of Philosophy in Neuroscience (PhD) - graduated in 2020

Upcoming Events

Next Deadlines

Upcoming Awards